Guggulsterone modulates MAPK and NF-κB pathways and inhibits skin tumorigenesis in SENCAR mice

Carcinogenesis

Volumn 29, Issue 10, 2008, Pages 2011-2018

  Sarfaraz, Sami ^a,b   Siddiqui, Imtiaz A ^a   Syed, Deeba N ^a   Afaq, Farrukh ^a   Mukhtar, Hasan ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CYCLOOXYGENASE 2; GUGGULSTERONE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; ORNITHINE DECARBOXYLASE; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPIDERMIS HYPERPLASIA; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SENSITIVE TO CARCINOGENESIS MOUSE; SKIN EDEMA; SKIN TUMOR;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CYCLOOXYGENASE 2 INHIBITORS; EDEMA; FEMALE; HYPERPLASIA; I-KAPPA B KINASE; I-KAPPA B PROTEINS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED SENCAR; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; ORNITHINE DECARBOXYLASE; PHOSPHORYLATION; PREGNENEDIONES; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 53349108487     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn180     Document Type: Article

References (52)

1. Gujral,M.L. et al. (1960) Antiarthritic and anti-inflammatory activity of gum guggul (Balsamodendron mukul Hook). Indian J. Physiol. Pharmacol., 4, 267-273.
2. Sharma,J.N. et al. (1977) Comparison of the anti-inflammatory activity of Commiphora mukul (an indigenous drug) with those of phenylbutazone and ibuprofen in experimental arthritis induced by mycobacterial adjuvant. Arzneimittelforschung, 27, 1455-1457.
3. Sinal,C.J. et al. (2002) Guggulsterone: An old approach to a new problem. Trends Endocrinol. Metab., 13, 275-276.
4. Urizar,N.L. et al. (2003) GUGULIPID: A natural cholesterol-lowering agent. Annu. Rev. Nutr., 23, 303-313.
5. Tripathi,Y.B. et al. (1988) Thyroid stimulatory action of (Z)-guggulsterone: Mechanism of action. Planta. Med., 4, 271-277.
6. Singh,B.B. et al. (2003) The effectiveness of Commiphora mukul for osteoarthritis of the knee: An outcomes study. Altern. Ther. Health Med., 9, 74-79.
7. Singh,S.V. et al. (2007) Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase. Cancer Res., 67, 7439-7449.
8. Shishodia,S. et al. (2007) Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products. Biochem. Pharmacol. 74, 118-130.
9. Slaga,T.J. et al. (1982) Studies on the mechanisms involved in multistage carcinogenesis in mouse skin. J. Cell. Biochem., 18 99-119.
10. Katiyar,S.K. et al. (1997) Inhibition of phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate-caused inflammatory responses in SENCAR mouse skin by black tea polyphenols. Carcinogenesis, 18, 1911-1916.
11. Katiyar,S.K. et al. (1996) Inhibition of tumor promotion in SENCAR mouse skin by ethanol extract of Zingiber officinale rhizome. Cancer Res., 56, 1023-1030.
12. Katiyar,S.K. et al. (1995) Inhibition of 12-O-tetradecanoylphorbol-13-acetate and other skin tumor-promoter-caused induction of epidermal interleukin-1 alpha mRNA and protein expression in SENCAR mice by green tea polyphenols. J. Invest. Dermatol., 105, 394-398.
13. Chun,K.S. et al. (2002) Effects of yakuchinone A and yakuchinone B on the phorbol ester-induced expression of COX-2 and iNOS and activation of NF-κB in mouse skin. J. Environ. Pathol. Toxicol. Oncol., 21, 131-139.
14. Seo,H.J. et al. (2002) Inhibitory effects of the standardized extract (DA-9601) of Artemisia asiatica Nakai on phorbol ester-induced ornithine decarboxylase activity, papilloma formation, cyclooxygenase-2 expression, inducible nitric oxide synthase expression and nuclear transcription factor kappa B activation in mouse skin. Int. J. Cancer 100, 456-462.
15. Afaq,F. et al. (2003) Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice. Oncogene, 22, 9254-9264.
16. Shishodia,S. et al. (2003) Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: Correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res., 63, 4375-4383.
17. Afaq,F. et al. (2005) Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-κB pathways and inhibits skin tumorigenesis in CD-1 mice. Int. J. Cancer, 113 423-433.
18. Saleem,M. et al. (2004) Lupeol modulates NF-κB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene, 23 5203-5214.
19. Takada,Y. et al. (2004) Flavopiridol inhibits NF-κB activation induced by various carcinogens and inflammatory agents through inhibition of Ikappa Balpha kinase and p65 phosphorylation: Abrogation of cyclin D1, cyclooxygenase-2 and matrix metalloprotease-9. J. Biol. Chem., 279, 4750-4759.
20. Bharti,A.C. et al. (2002) Chemopreventive agents induce suppression of nuclear factor-kappaB leading to chemosensitization. Ann. N. Y. Acad. Sci., 973, 392-395.
21. Israel,A. (1995) A role for phosphorylation and degradation in the control of NF-kappa B activity. Trends Genet., 11, 203-205.
22. Afaq,F. et al. (2003) Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea constituent (-)-epigallocatechin-3-gallate. Oncogene, 22, 1035-1044.
23. Tanaka,T. et al. (1986) Tannins and related compounds: XLI, isolation and characterization of novel ellagitannins, puicacorteins A, B, C and D, and punigluconin from the bark of Punicum granatum. L. Chem. Pharm. Bull., 34, 656-663.
24. Baldwin,A.S.Jr (1996) The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu. Rev. Immunol., 14, 649-683.
25. Maniatis,T. (1997) Catalysis by a multiprotein IkappaB kinase complex. Science, 278, 818-819.
26. Bickers,D.R. et al. (2000) Novel approaches to chemoprevention of skin cancer. J. Dermatol., 27, 691-695.
27. Ding,M. et al. (2004) Inhibition of AP-1 and neoplastic transformation by fresh apple peel extract. J. Biol. Chem., 279 10670-10676.
28. DiGiovanni,J. (1991) Modification of multistage carcinogenesis. In Ito,N. and Sugano,H. (eds.) Modification of Tumor Development in Rodents: Progress in Experimental Tumor Research. Vol. 33. Karger, Basel, Switzerland, pp. 192-229.
29. Katiyar,S.K. et al. (1997) Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J. Natl Cancer Inst., 89, 556-566.
30. Thomas,T. et al. (2003) Polyamine metabolism and cancer. J. Cell. Mol. Med., 7, 113-126.
31. Einspahr,J.G. et al. (2003) Skin cancer chemoprevention: strategies to save our skin. Recent Results Cancer Res., 163 151-164.
32. Ahmad,N. et al. (2001) A definitive role of ornithine decarboxylase in photocarcinogenesis. Am. J. Pathol., 159, 885-892.
33. Auvinen,M. (1997) Cell transformation, invasion, and angiogenesis: A regulatory role for ornithine decarboxylase and polyamines? J. Natl Cancer Inst., 89, 533-537.
34. Mohan,R.R. et al. (1999) Overexpression of ornithine decarboxylase in prostate cancer and prostatic fluid in humans. Clin. Cancer Res. 5, 143-147.
35. Verma,A.K. et al. (1979) Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion. Cancer Res., 39, 419-425.
36. Nakadate,T. et al. (1985) Inhibition of teleocidin-caused epidermal ornithine decarboxylase induction by phospholipase A2-, cyclooxygenase- and lipoxygenase-inhibitors. Jpn. J. Pharmacol., 37, 253-258.
37. Bhimani,R.S. et al. (1993) Inhibition of oxidative stress in HeLa cells by chemopreventive agents. Cancer Res., 53, 4528-4533.
38. Herschman,H.R. (1994) Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev., 13, 241-256.
39. Smith,W.L. et al. (1996) Prostaglandin endoperoxide H synthases (cyclo-oxygenases)-1 and -2. J. Biol. Chem., 271, 33157-33160.
40. Furstenberger,G. et al. (1985) In Fischer,S.M. and Slaga,T.J. (eds.) Arachidonic Acid Metabolism and Tumor Promotion. Martinus Nijhoff Publishing, Boston, MA, pp. 49-72.
41. Kim,D.J. et al. (2003) Chemoprevention of colon cancer by Korean food plant components. Mutat. Res., 523-524, 99-107.
42. Shishodia,S. et al. (2004) Guggulsterone inhibits NF-κB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J. Biol. Chem., 279, 47148-47158.
43. Chen,W. et al. (1998) UVB irradiation-induced activator protein-1 activation correlates with increased c-fos gene expression in a human keratino-cyte cell line. J. Biol. Chem., 273, 32176-32181.
44. Zhu,W.H. et al. (2002) Regulation of angiogenesis by vascular endothelial growth factor and angiopoietin-1 in the rat aorta model: distinct temporal patterns of intracellular signaling correlate with induction of angiogenic sprouting. Am. J. Pathol., 161, 823-830.
45. Potapova,O. et al. (2000) c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells. J. Biol. Chem., 275 24767-24775.
46. Huang,C. et al. (1998) Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc. Natl Acad. Sci. USA, 95, 156-161.
47. Adderley,S.R. et al. (1999) Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. J. Biol. Chem., 274, 5038-5046.
48. Carter,A.B. et al. (1999) The p38 mitogen-activated protein kinase is required for NF-κB-dependent gene expression: The role of TATA-binding protein (TBP). J. Biol. Chem., 274, 30858-30863.
49. Karin,M. et al. (2000) Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annu. Rev. Immunol., 18, 621-663.
50. Garg,A. et al. (2002) Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia, 16, 1053-1068.
51. Epinat,J.C. et al. (1999) Diverse agents act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway. Oncogene, 18, 6896-6909.
52. Na,H.K. et al. (2006) Transcriptional regulation via cysteine thiol modification: A novel molecular strategy for chemoprevention and cytoprotection. Mol. Carcinog., 45, 368-380.